Dr. Ginsburg is the founding director for Genomic Medicine in the Duke Institute for Genome Sciences & Policy and the founding executive director of the Center for Personalized Medicine in the Duke University Health System.  He is a professor of Medicine, Pathology, and Biomedical Engineering at Duke University.  He is an internationally recognized expert in genomics and personalized medicine with funding from NIH, DOD, Air Force, DARPA, the Gates Foundation, and industry.  Prior to Duke he was at Millennium Pharmaceuticals Inc where he was vice president of Molecular and Personalized Medicine and responsible for developing pharmacogenomic and biomarker strategies for therapeutics.

He serves as an expert panel member for Genome Canada, as a member of the Board of External Experts for the NHLBI, as Co-Chair of the Institute of Medicine’s Roundtable on Genome-Based Research to Human Health, as a member of the advisory council for the National Center for Accelerating Translational Science, as co-Chair of the Cures Acceleration Network, as an Expert Advisor to the Pharmacogenetics Research Network, and as a member of the World Economics Forum’s Global Agenda Council on Personalized and Precision Health Care.

Share The Story